Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | SHBG | P04278 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 8/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL9388963 | 0.98 | CYP1A2 (0.35) | CYP1A2SIGMAR1TSHRSHBGEPHX1 | |
| SCHEMBL14914859 | 0.81 | CYP1A2 (0.36) | CYP1A2SIGMAR1TSHRSHBGEPHX1 | |
| SCHEMBL27932234 | 0.80 | CYP1A2 (0.38) | CYP1A2SIGMAR1SHBG | |
| SCHEMBL14914768 | 0.79 | CYP1A2 (0.33) | CYP1A2SIGMAR1TSHRSHBGEPHX1 | |
| SCHEMBL28248889 | 0.76 | TSHR (0.33) | CYP1A2TSHR | |
| SCHEMBL15657452 | 0.76 | CYP1A2 (0.35) | CYP1A2SHBG | |
| SCHEMBL6722060 | 0.76 | CYP1A2 (0.36) | CYP1A2SIGMAR1TSHRSHBGEPHX1 | |
| SCHEMBL6722061 | 0.76 | CYP1A2 (0.36) | CYP1A2SIGMAR1TSHRSHBGEPHX1 | |
| Ammonia Solution, Strong SCHEMBL10451786 | 0.75 | CYP1A2 (0.37) | CYP1A2SIGMAR1TSHRSHBGEPHX1 | |
| SCHEMBL15657640 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12172147-B2 | Catalyst composition for selective hydrogenation with improved characteristics | Sud Chemie, Inc. (US) | 2024-12-24 | — | — | US | claimed |
| US-12172148-B2 | Catalyst composition for selective hydrogenation with improved characteristics | Sud Chemie, Inc. (US) | 2024-12-24 | — | — | US | claimed |
| CN-113201384-B | Lubricant composition containing ionic liquid | 克鲁勃润滑剂慕尼黑两合欧洲公司 | 2023-10-24 | — | — | CN | claimed |
| US-20200101446-A1 | CATALYST COMPOSITION FOR SELECTIVE HYDROGENATION WITH IMPROVED CHARACTERISTICS | CLARIANT INTERNATIONAL LTD. (CH) | 2020-04-02 | — | — | US | claimed |
| EP-2583751-B1 | Catalyst composition for selective hydrogenation with improved characteristics | CLARIANT PRODUKTE DEUTSCHLAND (DE) | 2014-12-03 | — | — | EP | claimed |
| WO-2013057244-A1 | CATALYST COMPOSITION FOR SELECTIVE HYDROGENATION WITH IMPROVED CHARACTERISTICS | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2013-04-25 | — | — | WO | claimed |
| US-20130102819-A1 | CATALYST COMPOSITION FOR SELECTIVE HYDROGENATION WITH IMPROVED CHARACTERISTICS | CLARIANT CORPORATION | 2013-04-25 | — | — | US | claimed |
| US-12172147-B2 | Catalyst composition for selective hydrogenation with improved characteristics | Sud Chemie, Inc. (US) | 2024-12-24 | — | — | US | disclosed |
| US-12172148-B2 | Catalyst composition for selective hydrogenation with improved characteristics | Sud Chemie, Inc. (US) | 2024-12-24 | — | — | US | disclosed |
| US-11634370-B2 | Selective hydrogenation methods | CLARIANT INTERNATIONAL LTD (CH) | 2023-04-25 | — | — | US | disclosed |
| US-11623902-B2 | Selective hydrogenation methods and catalysts | CLARIANT INTERNATIONAL LTD (CH) | 2023-04-11 | — | — | US | disclosed |
| CN-115768737-A | Selective hydrogenation process | 科莱恩国际有限公司 | 2023-03-07 | — | — | CN | disclosed |
| CN-115715280-A | Selective hydrogenation process and catalyst | 科莱恩国际有限公司 | 2023-02-24 | — | — | CN | disclosed |
| US-20200123082-A1 | SELECTIVE HYDROGENATION METHODS | CLARIANT INTERNATIONAL LTD (CH) | 2020-04-23 | — | — | US | disclosed |
| US-20200101446-A1 | CATALYST COMPOSITION FOR SELECTIVE HYDROGENATION WITH IMPROVED CHARACTERISTICS | CLARIANT INTERNATIONAL LTD. (CH) | 2020-04-02 | — | — | US | disclosed |
| US-20200094226-A1 | CATALYST COMPOSITION FOR SELECTIVE HYDROGENATION WITH IMPROVED CHARACTERISTICS | CLARIANT INTERNATIONAL LTD. (CH) | 2020-03-26 | — | — | US | disclosed |
| EP-2583751-B1 | Catalyst composition for selective hydrogenation with improved characteristics | CLARIANT PRODUKTE DEUTSCHLAND (DE) | 2014-12-03 | — | — | EP | disclosed |
| WO-2013057244-A1 | CATALYST COMPOSITION FOR SELECTIVE HYDROGENATION WITH IMPROVED CHARACTERISTICS | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2013-04-25 | — | — | WO | disclosed |
| US-20130102819-A1 | CATALYST COMPOSITION FOR SELECTIVE HYDROGENATION WITH IMPROVED CHARACTERISTICS | CLARIANT CORPORATION | 2013-04-25 | — | — | US | disclosed |
| EP-2583751-A1 | Catalyst composition for selective hydrogenation with improved characteristics | Clariant Produkte (Deutschland) GmbH (DE) | 2013-04-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12172147-B2 | Catalyst composition for selective hydrogenation with improved characteristics | BET1, EP300, H1-2 | CYP1A2 1095/4885SIGMAR1 1348/4885TSHR 2340/4885 |
| US-20200101446-A1 | CATALYST COMPOSITION FOR SELECTIVE HYDROGENATION WITH IMPROVED CHARACTERISTICS | BET1, EP300, H1-2 | CYP1A2 1095/4885SIGMAR1 1348/4885TSHR 2340/4885 |
| US-12172148-B2 | Catalyst composition for selective hydrogenation with improved characteristics | BET1, EP300, H1-2 | CYP1A2 1095/4885SIGMAR1 1348/4885TSHR 2340/4885 |
| US-20200123082-A1 | SELECTIVE HYDROGENATION METHODS | KAT8, KAT7, TDO2 | CYP1A2 1954/4885SIGMAR1 2654/4885TSHR 3953/4885 |
| US-11634370-B2 | Selective hydrogenation methods | KAT8, KAT7, TDO2 | CYP1A2 1954/4885SIGMAR1 2654/4885TSHR 3953/4885 |
| US-20200094226-A1 | CATALYST COMPOSITION FOR SELECTIVE HYDROGENATION WITH IMPROVED CHARACTERISTICS | BET1, EP300, H1-2 | CYP1A2 1095/4885SIGMAR1 1348/4885TSHR 2340/4885 |
| US-11623902-B2 | Selective hydrogenation methods and catalysts | KAT8, ITGAV, ASNS | CYP1A2 2562/4885SIGMAR1 4081/4885TSHR 2995/4885 |
| US-20130102819-A1 | CATALYST COMPOSITION FOR SELECTIVE HYDROGENATION WITH IMPROVED CHARACTERISTICS | BET1, EP300, H1-2 | CYP1A2 1408/4885SIGMAR1 1332/4885TSHR 2201/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.